Subscribe To

Price Alert Latest News Economic Calendar News

CLPBF / Coloplast A/S (CLPBF) Q3 2023 Earnings Call Transcript

Coloplast A/S (OTCPK:CLPBF) Q3 2023 Earnings Call Transcript August 17, 2023 4:30 AM ET Company Participants Kristian Villumsen - President and Chief Executive Officer Anders Lonning-Skovgaard - Chief Financial Officer Conference Call Participants Maja Pataki - Kepler Cheuvreux Hassan Al-Wakeel - Barclays Christian Ryom - Danske Bank Veronika Dubajova - Citi Shubhangi Gupta - HSBC Robert Davies - Morgan Stanley Christoph Gretler - CS Samuel England - Berenberg Graham Doyle - UBS Operator Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Coloplast Nine Months 2022/2023 Earnings Release Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Coloplast

CLPBF

2023

Earnings

Call

Transcript

clpbf

Stock

Posted: Aug 17 2023, 14:20

Author Name: Seeking Alpha

CLPBF News

By Seeking Alpha
August 17, 2023

Coloplast A/S (CLPBF) Q3 2023 Earnings Call Transcript

Coloplast A/S (OTCPK:CLPBF) Q3 2023 Earnings Call Transcript August 17, 2023 4:30 AM ET Company Participants Kristian Villumsen - President and Chief

By Reuters
July 7, 2023

Denmark's Coloplast buys Kerecis for up to $1.3 bln

Danish medical equipment maker Coloplast has agreed to buy Iceland-based biologic wound care firm Kerecis for up to $1.3 billion, it said on Friday.

By Seeking Alpha
February 3, 2023

Coloplast A/S (CLPBF) Q1 2023 Earnings Call Transcript

Coloplast A/S (OTCPK:CLPBF) Q1 2023 Earnings Conference Call February 3, 2023 5:00 AM ET Company Participants Kristian Villumsen - President and CEO A

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.